Novartis International AG

SWF:NOVN ISIN:CH0012005267

Novartis offers a wide range of healthcare products through our Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health Divisions. 
 
  

View in Other Languages

News

CFO Summit Europe 2011 To Focus On Compliance, Governance And The Impact of Regulatory Change

🕔5/17/2011 5:49:30 PM 6860

Compliance, governance and the impact of regulatory change are just some of the issues that will no doubt be on the agenda at the CFO Summit Europe 2011, which takes place from 13-15 September at The Oitavos, Cascais in Portugal. This closed-door summit, hosted by GDS International, features some of the leading voices in the European CFO sector, including Ramon Zapata, Head of Finance Operations at Novartis (NYSE:NVS); Olivier Klaric, VP Treasury at Sanofi Aventis Group (NYSE:SNY); Erik Ter Horst, CFO EMEA and VP of Finance for BT (NYSE:BT); and Clive Parrit, Vice President of the Institute of Chartered Accountants.

Read Full Article

Novartis International AG (VTX:NOVN) Rasilez®, First-in-class Direct Renin Inhibitor, Provides Greater Reduction In High Blood Pressure Than ACE Inhibitor Ramipril In Patients 65 And Older

🕔11/12/2008 2:33:00 AM 6159

Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) Rasilez HCT®, Single-pill Combination Of Rasilez® And Diuretic, Receives Swiss Approval For The Treatment Of High Blood Pressure

🕔10/29/2008 5:19:00 PM 5244

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) ACZ885 Phase III Data Show Rapid, Sustained Clinical Remission In Children And Adults Suffering From A Group Of Rare, Potentially Life-threatening Autoinflammatory Diseases

🕔10/27/2008 5:17:00 PM 6677

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) Novartis To Acquire Nektar Therapeutics Pulmonary Business Unit, Strengthening Respiratory Drug Delivery Capabilities

🕔10/21/2008 4:17:00 PM 3881

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) Novartis Delivers Sustained Strong Performance In First Nine Months Of 2008 Underpinned By Accelerating Growth In Pharmaceuticals

🕔10/20/2008 3:03:00 PM 6578

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) Early Data Show Potential For Imatinib To Treat Life-threatening Form Of Pulmonary Artery Disease

🕔10/8/2008 3:17:00 PM 6398

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) New Phase II Data On NVA237, A Novel Once-daily Treatment For COPD, show Promising Efficacy And Tolerability With Potentially Faster Onset Than Tiotropium

🕔10/7/2008 3:17:00 PM 4140

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) New Study Shows Potential Benefits Of Innovative Xolair® Anti-ige Therapy In Treating Children Suffering From Moderate-to-severe Allergic Asthma

🕔10/6/2008 3:17:00 PM 2463

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Novartis International AG (SWF:NOVN) Once-yearly Aclasta® Approved In EU To Treat Osteoporosis In Men And To Reduce Risk Of New Fractures Following Hip Fracture Both In Men And Postmenopausal Women

🕔9/30/2008 3:17:00 PM 4646

Novartis International AG (SWF:NOVN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article
###

51,082 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 95) (Last 30 Days: 298) (Since Published: 22774) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Pharmaceutical 
  • Homepage
  • www.novartis.com